Funding for this research was provided by:
National Health and Medical Research Council (#1060407, #1005668, #1091878, #1041472, #1073858)
Text and Data Mining valid from 2018-11-03
Received: 7 May 2018
Accepted: 25 October 2018
First Online: 3 November 2018
Compliance with ethical standards
: LD and BL have received untied educational grants from Reckitt Benckiser, Mundipharma and Seqirus to conduct post-marketing surveillance of new opioid medications in Australia. LD, BL and SL have also received untied educational grants from Indivior. No company had any knowledge or involvement in this study.